EMCL AbD Tecartus
Laufzeit: 01.01.2023 - 31.12.2028
imported
Kurzfassung
Real world effectiveness and safety of BrexuCel vs patient-individual therapy in relapsed/refractory MCL: A European Mantle Cell Lymphoma Network (EMCL) registry study mandated by the G-BA
